To investigate whether these results were clinically relevant, we collected 6 matched GBM tissues from the initial surgery of untreated tumors and from the second surgery after treatment failure with IR and temozolomide chemotherapy, to evaluate Tie2 expression by immunohistochemistry analysis. This evidence concerns the gene TEK and glioblastoma.